Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)
24 juil. 2012 08h35 HE
|
P2D Bioscience
CINCINNATI, OH and BANGALORE, INDIA--(Marketwire - Jul 24, 2012) - Advinus Therapeutics Ltd., a drug discovery and development company, and P2D Bioscience, a CNS-focused specialty...